| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Physiology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N 5E5
 |
ABSTRACT |
|---|
 TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
H2S is endogenously generated in vascular smooth muscle cells. The signal transduction pathways involved in the vascular effects of H2S have been unclear and were investigated in the present study. H2S induced a concentration-dependent relaxation of rat aortic tissues that was not affected by vascular denervation. The vasorelaxant potency of H2S was attenuated by the removal of the endothelium. Similarly, the blockade of nitric oxide synthase or the coapplication of the Ca2+-dependent K+ channel blockers apamin and charybdotoxin reduced the H2S-induced relaxation of the endothelium-intact aortic tissues. Sodium nitroprusside (SNP)-induced relaxation was completely abolished by either 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one (ODQ) or NS- 2028, two soluble guanylate cyclase inhibitors. Instead of inhibition, ODQ and NS-2028 potentiated the H2S-induced vasorelaxation, which was suppressed by superoxide dismutase. The vasorelaxant effect of H2S was also significantly attenuated when Ca2+-free bath solution was used. Finally, pretreatment of aortic tissues with H2S reduced the relaxant response of vascular tissues to SNP. Our results demonstrate that the vascular effect of H2S is partially mediated by a functional endothelium and dependent on the extracellular calcium entry but independent of the activation of the cGMP pathway.
aorta; guanosine 3',5'-cyclic monophosphate; endothelium
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
H2s has been
generally considered as a toxic gas found in the contaminated
environmental atmosphere. Its major toxic effects are the toxication of
central nervous system and the inhibition of the respiratory system
(2, 10, 28). H2S can also be produced
endogenously from L-cysteine by cystathionine 
-synthase (CBS) and/or cystathionine 
-lyase (CSE) (23, 24). The
expression of these enzymes has been detected in various tissues
(13). Our recent study (31) demonstrated that
CSE was expressed in the rat aorta, tail artery, mesenteric artery, and
pulmonary artery, whereas the expression of CBS was not detectable.
Under physiological conditions, tissue content of H2S in
the brain has been determined to be between 50 and 160 µM
(1). The endogenous production of H2S from rat
vascular tissues has also been demonstrated in our previous study
(31). With the use of a modified sulfide electrode method,
the H2S concentration of rat serum was determined to be
~46 µM (31). These observations speak for the
potential physiological functions of H2S in the
cardiovascular system.
The relaxant effects of exogenously applied H2S on intestinal and vascular smooth muscles have been reported (13). In both the aorta and portal vein of rats, H2S induced a dose-dependent relaxation, but other thiol-containing endogenous substances such as cysteine and glutathione did not have any vasorelaxant effect (13). More importantly, we found that H2S relaxed rat aortic tissues within physiologically relevant concentrations and that an intravenous bolus injection of H2S transiently decreased blood pressure of rats (31). Thus the physiological effect of H2S on vascular functions should be entertained.
The reported vascular effects of H2S are not always consistent in terms of the relaxant potency of the gas and its interaction with other vasoactive factors (13, 31). The mechanisms underlying the vascular effect of H2S are not completely understood yet, although the activation of ATP-sensitive K+ (KATP) channels in vascular smooth muscle cells (SMCs) might play an important role (31). Whether the vascular effects of H2S are mediated by vasoactive factors released from the endothelium or peripheral nerve endings, e.g., nonadrenergic, noncholinergic (NANC) nerves, is not clear. The interaction of H2S with different cellular signaling pathways in vascular SMCs, including cGMP and oxygen-derived free radicals, has not been systematically examined. The objective of the present study, therefore, was to characterize the relaxant effect of H2S on rat aortic tissues and study the possible cellular and molecular mechanisms underlying the H2S-induced relaxation. To this end, we systematically examined the roles of the endothelium, peripheral innervation, cellular cGMP signaling pathway, and extracellular Ca2+ concentration ([Ca2+]) in the vasorelaxant response to H2S. The interaction of H2S and nitric oxide (NO) on vascular tone was also examined.
| |
MATERIALS AND METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Measurement of isometric contraction of vascular tissues. Male Sprague-Dawley rats (10-12 wk old) were housed in an animal care facility at the College of Medicine, University of Saskatchewan. Animal experiment protocols were approved by the Committee on Animal Care and Supply of the University of Saskatchewan. The method for measurement of isometric tension development of the isolated rat aortic tissues was the same as that described previously (26). In brief, the aortic rings were mounted on two tungsten wires with one immobilized and the other connected to a transducer (FT 03, Grass Instruments) in organ baths. The baths were filled with 10 ml Krebs bicarbonate solution composed of (in mM) 115 NaCl, 5.4 KCl, 2.5 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, 25 NaHCO3, and 11 D-glucose bubbled with 5% CO2 in oxygen. The aortic rings were mechanically stretched to achieve a basal tension of ~2.0 g and allowed to equilibrate for 1 h before the start of the experiment. The endothelium was kept functionally undamaged. In the experiment where the removal of endothelium was specified, vascular tissues were incubated in Krebs solution containing 0.1% saponin for 55 s and then rinsed with normal Krebs solution (3). The absence of a functional endothelium was verified by the failure of acetylcholine (1 µM) to induce relaxation of the precontracted vascular tissues. For the experiments where DMSO was used as the vehicle, the control experiments also received the same volume of DMSO (usually 10 µl in 10 ml bath solution) as used in dissolving chemicals. The aortic tissues were precontracted with submaximal dose of phenylepherine (PE; 0.3 µM). Data acquisition and analysis were accomplished with a Biopac System (Biopac Systems) including MP100 WS acquisition units, TCI 100 amplifiers, AcKnowledge software version 3.01, and a personal computer.
Chemicals and data analysis.
The H2S-saturated solution (0.09 M at 30°C) was made by
bubbling pure H2S gas (Praxair; Mississauga, Ontario,
Canada) into Krebs solution at 30°C for 40 min. Both the
H2S gas-saturated solution and NaHS (Aldrich; Milwaukee,
WI) stock solution (1 M) were freshly prepared on the day of the
experiment. The stock solutions of H2S were directly added
to the bath solution to achieve the final concentration of
H2S. At 37°C, the concentration of H2S of the
bath solution was relatively stable. Direct measurement of
H2S concentration with our established assay
(31) showed that the stability of H2S in the
bath solution varied depending on the initial H2S
concentrations. At the highest concentration tested (1 mM), a drop of
the H2S concentration around 15% within 30 min was
observed (Fig. 1).
|
| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Vasorelaxation induced by NaHS and H2S gas.
Both NaHS solution and the H2S gas-bubbled solution have
been used in the literature to relax vascular tissues. The
concentration-dependent relaxant effects of NaHS and the
H2S gas-bubbled solution on the PE-precontracted aorta were
compared in the present study. The H2S gas-bubbled solution
induced vasorelaxation with an IC50 of 124.7 ± 14.4 µM, similar to that induced by NaHS solution with an IC50
of 135.5 ± 14 µM (P > 0.05). Both the
H2S gas-bubbled solution and NaHS solution had the same
threshold concentration of 60 µM at which vasorelaxation was
initiated. A maximum relaxation of 55.3% was attained at 600 µM
NaHS. In addition, vasorelaxation induced by both NaHS and
H2S could be reversed by removing the chemicals (Fig.
2A). Because the majority of
experiments were carried out using NaHS solution, for the convenience
of description, the term of H2S was used in the rest of
this communication. The use of the H2S gas-bubbled solution
in each individual experiment was specified.
|
Effect of denervation on H2S-induced vasorelaxation. To test whether the vascular effect of H2S was mediated by autonomous or NANC (12, 18) nerve endings remaining in the vascular wall, the H2S-induced vasorelaxation was examined using aortic tissues pretreated with a phenol denervation procedure (27) in which tissues were immersed in 0.75% phenol-6.75% ethanol for 20 s. The basal tension and contraction force were not altered by this treatment. The vasorelaxant effect of H2S appeared to be potentiated (Fig. 2B). H2S (600 µM) induced a 74.5 ± 9.1% relaxation of the denervated vascular tissues (n = 8) compared with the 55.3 ± 3.4% relaxation induced by H2S at the same concentration (n = 8). However, the difference was not statistically significant (P > 0.05). These results suggest that the vasorelaxant effect of H2S is not due to the altered neurotransmitter release from the autonomous or NANC nerve endings.
Interaction of H2S and endothelium on H2S-induced vasorelaxation. After removal of the endothelium with saponin treatment, the total contraction force induced by 0.3 µM PE was changed from 1.18 ± 0.05 to 1.30 ± 0.10 g (P > 0.05). The H2S-induced maximum relaxation of the precontracted tissues was not affected by the endothelium removal, but the H2S concentration-response curve was shifted to the right, with IC50 changed from 135.5 ± 14 to 273 ± 16 µM (P < 0.05). Thus the H2S-induced vasorelaxation might be partially facilitated by an endothelium-mediated mechanism (Fig. 2B).
The endothelium releases many vasoactive factors that regulate vascular smooth muscle contractility, including NO and endothelium-derived hyperpolarizing factor (EDHF). Application of NG-nitro-L-arginine methyl ester (L-NAME; 100 µM), which would limit endogenous NO production, to the endothelium-intact tissues increased the IC50 of H2S from 135.5 ± 14 to 220 ± 12 µM (P < 0.05), indicating that the vasorelaxant effect of H2S was reduced in the presence of L-NAME. The coapplication of the Ca2+-dependent K+ (KCa) channel blockers apamin and charybdotoxin has been reported to effectively inhibit the vasorelaxation mediated by EDHF (7). This protocol was used in the present study to further test the involvement of EDHF in the vascular effect of H2S. In the presence of apamin (50 nM) and charybdotoxin (50 nM for 30 min), the H2S concentration-response curve of the endothelium-intact aortic tissues was significantly shifted to the right, with IC50 changed from 135.5 ± 14 to 350 ± 13 µM (P < 0.05), an effect similar to the removal of the endothelium (Fig. 3A). Like the removal of the endothelium, the maximal relaxation induced by H2S was not affected by the coapplication of apamin and charybdotoxin. Charybdotoxin (100 nM) alone did not cause any significant shift of the H2S concentration-response curve (IC50 from 128.5 ± 62.4 to 183.2 ± 10.3 µM, P > 0.05). Apamin alone (50 nM) also did not affect the H2S-induced vasorelaxation (Fig. 3B). The basal contraction force was not significantly affected by these treatments.
|
Involvement of the cGMP pathway in H2S-induced
vasorelaxation.
The cGMP pathway plays an important role in mediating the NO- and
carbon monoxide (CO)-induced vasorelaxation (9). To
determine whether the H2S-induced vasorelaxation was
mediated by this pathway, we studied the vascular effect of
H2S in the presence of the soluble guanylyl cyclase (sGC)
inhibitors ODQ (10 µM for 20 min) (14, 29) and NS-2028
(1 µM for 20 min) (16), respectively. The basal tension
of the endothelium-intact aortic tissue was not significantly affected
by these reagents per se. Interestingly, instead of an inhibition, the
H2S-induced relaxation was potentiated by ODQ or NS-2028.
In the presence of ODQ, the relaxation induced by 1.8 mM
H2S was increased from 57.6 ± 3.5% to 94.9 ± 5.6% (P < 0.05) (Fig.
4A). NS-2028 enhanced the
H2S-induced relaxation from 70.1 ± 3.5% to 89.7 ± 3.5% (P < 0.05) (Fig. 4B). On the other hand, the blockade of the cGMP pathway by ODQ (10 µM) or NS-2028 (1 µM) significantly inhibited the SNP-induced vasorelaxation by >90%
(Fig. 5A). These results
suggest that the H2S-induced vasorelaxation is not due to
the activation of the cGMP pathway.
|
|
Influence of extracellular [Ca2+] entry on H2S-induced vasorelaxation. The transmembrane movement of Ca2+ directly affects the contractility of smooth muscles. To examine whether the H2S-induced relaxation was mediated by an extracellular [Ca2+]-dependent mechanism, the concentration-dependent vasorelaxant effect of H2S was studied either using a calcium-free bath solution or with the normal bath solution but in the presence of nifedipine, a voltage-gated Ca2+ channel inhibitor (19). When calcium-free bath solution was used, PE (0.3 µM) generated a contraction force of 0.53 ± 0.04 g, which was 34% of the contraction force in the presence of calcium. Interestingly, PE induced an initial transient contraction spike in three of eight tissues, but a sustained plateau was always developed after the spike in these tissues. The relative changes of the H2S-induced relaxation were always calculated based on the force generated at the sustained plateau.
A transient increase in basal tension was also observed after the addition of nifedipine to the bath solution. This increase amounted to up to ~15% of the PE-induced contraction and lasted for ~5 min. After the nifedipine-induced transient contraction subsided, PE was added to the bath solution, which generated a contraction force that was 88 ± 14% of that in the absence of nifedipine (P < 0.05). These contractions were fairly sustained and maintained at plateaus during the course of experiments. The H2S (600 µM)-induced relaxation was reduced by 59.3 ± 8.3% by nifedipine (P < 0.05) or by 50 ± 6.3% by removing calcium from the bath solution (P < 0.05) (Fig. 6).
|
Interaction between H2S and SNP on vascular
contractility.
To identify whether there was a synergistic effect of NO and
H2S in relaxing vascular tissues, the
concentration-dependent effect of SNP, a NO donor, on the
H2S-pretreated (30 or 60 µM for 15 min) and
PE-precontracted endothelium-intact aortic tissue was examined. No
significant relaxation was induced by H2S per se at 30 or
60 µM. As shown in Fig. 7, the presence
of 30 µM H2S did not affect the vasorelaxant effect of
SNP. However, the presence of 60 µM H2S shifted the SNP
concentration-response curve to the right, with IC50
changed from 6.8 ± 0.5 to 34.2 ± 3.9 nM (P < 0.05), indicating that H2S inhibited the SNP-induced
vasorelaxation. On the contrary, the H2S-induced
vasorelaxation was not significantly affected by pretreating tissues
with 3 nM SNP (data not shown).
|
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
H2S has been tagged as a toxic gas for hundreds of
years (20). As a broad-spectrum toxicant, H2S
affects many organ systems, including the lung, brain, kidney, etc.
(2). However, the possible physiological effect of this
gas on the cardiovascular system has only been known recently. Hosoki
et al. (13) reported that NaHS relaxed vascular smooth
muscles, including the portal vein and aorta. The maximum relaxation of
rat aortic tissues (~30%) was achieved with 1 mM NaHS. The same
concentration of NaHS induced a nearly 100% relaxation in the portal
vein (13). The mechanisms for the NaHS-induced
vasorelaxation were not further investigated by these authors
(13). Our present study demonstrates that both the
H2S gas-saturated solution and NaHS relax PE-precontracted rat aortic tissues. In our study, the vasorelaxant potency of H2S is greater than that reported by Hosoki et al.
(13). At 180 µM, H2S already relaxes the
aortic tissues by 44.5% in our study. This discrepancy could be
explained by subtle differences in the handling of vascular tissues in
different laboratories. Our study demonstrates that a small increase in
H2S concentrations induces a significant relaxation. The
steepness of the concentration-relaxation curve indicates that the
vascular tissues are extremely sensitive to H2S within a
narrow concentration range. Possibly, there are several binding sites
for H2S on vascular smooth muscles, as suggested by a Hill
coefficient of 4.9 (22). This positive cooperativity indicates that the binding sites on vascular tissues for
H2S must be fully occupied and activated before a relaxant
response can be elicited (30). Could the intrinsic
H2S in the blood vessel wall reach the concentration range
between 60 and 600 µM under physiological conditions? It has been
shown that the producing rate of H2S in brain tissue was
~20 nM · min
1 · g
protein1 and its local concentration was ~100 µM
(range from 50 to 160 µM) (1, 28). We have reported that
the H2S production rates were 3.6 ± 1.3, 8.7 ± 2.7, and 3.4 ± 0.7 nmol · min1 · g
tissue1 for the aorta, tail artery, and mesenteric
artery, respectively (31). According to these production
rates, the concentration of H2S in smooth muscle can be
~100 µM in certain blood vessel walls. As such, SMCs in vivo may
well be exposed to endogenous H2S at concentrations close
to the effective concentration range of exogenous H2S used
in the present study.
We show in the present study that the vasorelaxant effect of H2S is mainly due to a direct interaction of H2S and SMCs, based on the failure of denervation to alter H2S effect and on the observation that H2S still significantly relaxed vascular tissues after endothelium removal. It is noteworthy, however, that a portion of the H2S-induced vasorelaxation was attenuated either by removal of the endothelium, by the application of L-NAME, or by the combined application of apamin-charybdotoxin to the endothelium-intact vascular tissues. These inhibitory effects were represented by the decrease in the vasorelaxant efficacy of H2S but not the amplitude of the relaxation (Figs. 2 and 3). Putatively, the endothelium might release certain factors in response to H2S stimulation to facilitate the relaxation of smooth muscles. Alternatively, the presence of an intact endothelium might retain H2S in the blood vessel wall so that its vasorelaxant effect can be potentiated and prolonged. The coapplication of apamin and charybdotoxin, a protocol to block the effect of EDHF (7), exerted a similar effect as endothelial removal, i.e., inducing a right shift of the H2S concentration-response curve. It thus appears that H2S may release EDHF from the vascular endothelium. The endothelium-derived NO is also likely released by H2S because the application of L-NAME to the endothelium-intact vascular tissues partially inhibits the H2S-induced vasorelaxation.
The NO- and CO-induced vasorelaxations are mainly mediated by the cGMP pathway (5, 9, 17). Depending on tissue types, another mechanism may be responsible for the vascular effects of NO and CO, i.e., the activation of large-conductance KCa channels in vascular SMCs (25, 26). Quite different from these two endogenous gases, H2S relaxed vascular tissues independent of the activation of the cGMP pathway or KCa channels. First, the H2S-induced vasorelaxation was not inhibited by ODQ and NS-2028. ODQ (10 µM) or NS-2028 (1 µM) has been shown to specifically inhibit sGC and reduce the production of cGMP (14, 16, 29). As shown in Fig. 5A, the vasorelaxant effect of SNP was inhibited by >90% in the presence of ODQ or NS-2028. In contrast, ODQ and NS-2028 even potentiated the vasorelaxant effect of H2S. The effects of these two agents argue strongly against the notion that the vascular effects of H2S are mediated by the activation of the cGMP pathway. The mechanisms underlying the synergistic effects of these sGC inhibitors and H2S on the vascular tone cannot be fully understood at the moment. Nevertheless, considering the inhibition of this synergistic effect by SOD, a superoxide scavenger, it is postulated that the interaction between ODQ or NS-2028 with H2S may have generated vasorelaxant free radicals (8) that further relaxed vascular tissues. Second, our previous and present studies have shown that neither iberiotoxin (31) nor charibdotoxin nor apamin alone (Fig. 3) had an effect on the H2S-induced vasorelaxation. Therefore, KCa channels in vascular SMCs are unlikely the target of H2S.
Because both H2S and NO are vasorelaxant factors, and they have different mechanisms of action, one may predict an additive effect when the two factors are administered together. Hosoki et al. (13) observed that the vasorelaxant effect of NO was enhanced by incubating rat aortic tissues with a low concentration of NaHS. In contrast, pretreating aortic tissues in our study with 60 µM H2S shifted the SNP concentration-response curve to the right (Fig. 7). In other words, H2S inhibits the vasorelaxant effect of SNP. The discrepancy between our results and those from the previous study (13) is not readily explainable. The experimental conditions of these studies are different. Hosoki et al. (13) used helical tissue strips of the aorta from Wistar rats, and we used aortic rings from Sprague-Dawley rats. The tissue damage of helical strips is certainly greater than that of ring preparations (4). This may also explain why, in the study by Hosoki et al. (13), the vasorelaxant potency of NaHS was much greater in portal vein rings than in aorta strips. Furthermore, 0.3 µM PE was used in our study, whereas 1 µM norepinephrine was used in the study of Hosoki et al. (13). It appears that the maximal contraction can be induced by 1 µM norepinephrine, whereas 0.3 µM PE (a submaximal concentration) only induces ~90% of the maximal contraction of rat aortic tissues. The advantage of using a submaximal concentration of PE is that the tissue can react with the relaxant agent in a more sensitive way (6, 11). Nevertheless, our results can be explained by the following hypothesis. Sulfide interacts with a number of enzymes and other macromolecules (10) and leads to the inhibition of cGMP accumulation (15). The inhibition of cGMP pathway by H2S per se may not suffice to alter the vascular tone, i.e., to evoke contraction. It might exert an inhibitory influence, however, on the SNP-induced vasodilation because the vasorelaxant effect of SNP is mainly mediated by the cGMP pathway.
Our novel observations can be summarized as the following. 1) The vasorelaxant effect of H2S is mainly mediated by an interaction of the gas with smooth muscles and partially by a functional endothelium. 2) The H2S-induced vasorelaxation is not mediated by the cGMP pathway, although the specific sGC inhibitors (ODQ and NS-2028) further strengthen the H2S-induced vasorelaxation through a novel mechanism. 3) The H2S-induced vasorelaxation is extracellular calcium entry dependent. These observations provide clues pertinent to the mechanisms for the H2S-induced vasorelaxation. Both endothelium and vascular smooth muscles may serve as the targets of H2S. By acting on the endothelium, H2S may facilitate the release of vasorelaxant factors, including NO and EDHF. By directly acting on vascular SMCs, H2S may reduce the extracellular calcium entry and relax vascular tissues. Our previous study has shown that H2S stimulated KATP channels in vascular SMCs (31). The opening of KATP channels leads to membrane hyperpolarization, which in turn may close voltage-gated Ca2+ channels. Alternatively, H2S may directly inhibit voltage-gated Ca2+ channels in vascular SMC, a possibility that merits further investigations.
Our study demonstrates that H2S relaxes vascular tissues in different mechanisms from those of NO and CO, although all of these three gas molecules are endogenously generated potent vasorelaxant factors. Furthermore, we show that a prior exposure to H2S reduces the relaxant response of vascular tissues to NO, but the presence of NO does not alter the vascular effect of H2S. The coordinated actions of these endogenous gases may provide an integrated modulation of vascular contractility.
| |
ACKNOWLEDGEMENTS |
|---|
The authors thank K. Safiniuk and G. Beal for technical assistance.
| |
FOOTNOTES |
|---|
This study was supported by the Natural Sciences and Engineering Research Council of Canada. R. Wang has been supported by an Investigator Award of Canadian Institutes of Health Research/Regional Partnership Program.
Address for reprint requests and other correspondence: R. Wang, Dept. of Physiology, College of Medicine, Univ. of Saskatchewan, Saskatoon, SK, Canada, S7N 5E5 (E-mail: wangrui{at}duke.usask.ca).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
April 18, 2002;10.1152/ajpheart.00013.2002
Received 9 January 2002; accepted in final form 14 April 2002.
| |
REFERENCES |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1.
Abe, K,
and
Kimura H.
The possible role of hydrogen sulfide as an endogenous neuromodulator.
J Neurosci
16:
1066-1071,
1996
2.
Beauchamp, RO, Jr,
Bus JS,
Popp JA,
Boveiko CJ,
and
Andjelkovich DA.
A critical review of the literature on hydrogen sulfide toxincity.
CRC Critical Reviews in Toxicology
13:
25-97,
1984[Medline].
3.
Buvinic, S,
and
Huidobro-Toro P.
Basal tonic release of nitric oxide coupled to cGMP production regulated the vascular reactivity of the mesenteric bed.
Eur J Pharmacol
424:
221-227,
2001[ISI][Medline].
4.
Calderone, V,
Martinotti E,
Scatizzi R,
Pellegrini A,
and
Breschi MC.
A modified aortic multiple-ring preparation for functional studies.
J Pharmacol Toxicol Methods
35:
131-138,
1996[ISI][Medline].
5.
Cohen, RA,
and
Vanhoutte PM.
Endothelium-dependent hyperpolarization beyond nitric oxide and cyclic GMP.
Circulation
92:
3337-3349,
1995
6.
Dainty, IA,
McGrath JC,
Spedding M,
and
Templeton AG.
The influence of the initial stretch and the agonist-induced tone on the effect of basal and stimulated release of EDRF.
Br J Pharmacol
100:
767-773,
1990[ISI][Medline].
7.
Doughty, JM,
Plane F,
and
Langton PD.
Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to the endothelium.
Am J Physiol Heart Circ Physiol
276:
H1107-H1112,
1999
8.
Fujimoto, S,
Asano T,
Sakai M,
Sakurai K,
Takagi D,
Yoshimoto N,
and
Itoh T.
Mechanisms of hydrogen peroxide-induced relaxation in rabbit mesenteric small artery.
Eur J Pharmacol
412:
291-300,
2001[ISI][Medline].
9.
Furchgott, RF,
and
Jothianandan D.
Endothelium-dependent and -independent vasodilatation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light.
Blood Vessels
28:
52-61,
1991[ISI][Medline].
10.
Guidotti, TL.
Hydrogen sulfide.
Occup Med
46:
367-371,
1996
11.
Hoiting, BH,
Meurs H,
Schuiling M,
Kuipers R,
Elzinga CR,
and
Zaagsma J.
Modulation of agonist-induced phosphoinositide metabolism, Ca2+ signalling and contraction of airway smooth muscle by cyclic AMP-dependent mechanisms.
Br J Pharmacol
117:
419-426,
1996[ISI][Medline].
12.
Holzer, P,
Wachter C,
Heinemann A,
Jocic M,
Lippe IT,
and
Herbert MK.
Sensory nerves, nitric oxide and NANC vasodilatation.
Arch Int Pharmacoldyn Ther
329:
67-79,
1995.
13.
Hosoki, R,
Matsuki N,
and
Kimura H.
The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide.
Biochem Biophysic Res Commun
237:
527-531,
1997[ISI][Medline].
14.
Hwang, T-L,
Wu C-C,
and
Teng C-M.
Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
Br J Pharmacol
125:
1158-1163,
1998[ISI][Medline].
15.
Kapoport, RM,
and
Murad F.
Effect of cyanide on nitrovasodilator-induced relaxation, cyclic GMP accumulation and guanylate cyclase activation in rat aorta.
Eur J Pharmacol
104:
61-70,
1984[ISI][Medline].
16.
Olesen, S-P,
Drejer J,
Axelsson O,
Moldt P,
Bang L,
Nielsen-Kudsk JE,
Busse R,
and
Mülsch A.
Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Br J Pharmacol
123:
299-309,
1998[ISI][Medline].
17.
Olson, LJ,
Knych ET, Jr,
Herzig TC,
and
Drewett JG.
Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation.
Hypertension
29:
254-261,
1997
18.
Park, JI,
Shin CY,
Lee YW,
Huh IH,
and
Sohn UD.
Endothelium-dependent sensory non-adrenergic non-cholinergic vasodilatation in rat thoracic aorta: involvement of ATP and a role for NO.
J Pharm Pharmacol
52:
409-416,
2000[ISI][Medline].
19.
Prisant, LM.
Calcium antagonists-pharmacologic considerations.
Ethn Dis
8:
98-102,
1998[Medline].
20.
Ramazzini, B.
Diseases of Workers (translated from the Latin text De morbis Artificum by Wright WC). Chicago, IL: University Chicago Press, 1964, p. 549. Reprinted in History Med 23: 1713, 1964.
21.
Rodriguez-Martinez, MA,
Garcia-Cohen EC,
Baena AB,
Gonzalez R,
Salaices M,
and
Marin J.
Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats. Endothelial modulation and mechanism involved.
Br J Pharmacol
125:
1329-1335,
1998[ISI][Medline].
22.
Ruiz, M,
Brown RL,
He Y,
Haley TL,
and
Karpen JW.
The single-channel dose-response relation is consistently steep for rod cyclic nucleotide-gated channels: implications for the interpretation of macroscopic dose-response relations.
Biochemistry
38:
10642-10648,
1999[Medline].
23.
Stipanuk, MH,
and
Beck PW.
Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat.
Biochem J
206:
267-277,
1982[ISI][Medline].
24.
Swaroop, M,
Bradley K,
Ohura T,
Tahara T,
Roper MD,
Rosenberg LE,
and
Kraus JD.
Rat cystathionine -synthase gene organization and alternative splicing.
J Biol Chem
267:
11455-11461,
1995.
25.
Wang, R.
Resurgence of carbon monoxide: an endogenous gaseous vasorelaxing factor.
Can J Physiol Pharmacol
76:
1-15,
1998[ISI][Medline].
26.
Wang, R,
Wang ZZ,
and
Wu L.
Carbon monoxide-induced vasorelaxation and the underlying mechanisms.
Br J Pharmacol
121:
927-934,
1997[ISI][Medline].
27.
Wang, Y,
and
Bukoski RD.
Use of acute phenolic denervation to show the neuronal dependence of Ca2+-induced relaxation of isolated arteries.
Life Sci
64:
887-894,
1999[ISI][Medline].
28.
Warenycia, MW,
Goodwin LR,
Benishin CG,
Reiffenstein RJ,
Francom DM,
Taylor JD,
and
Dieken FP.
Acute hydrogen sulfide poisoning: demonstration of selective uptake of sufide by the brain stem by measurement of brain sulfide levels.
Biochem Pharmacol
38:
973-981,
1989[ISI][Medline].
29.
Weisbrod, RM,
Griswold MC,
Yaghoubi M,
Komalavilas P,
Lincoln TM,
and
Cohen RA.
Evidence that additional mechanisms to cyclic GMP mediate the decrease in intracellular calcium and relaxation of rabbit aortic smooth muscle to nitric oxide.
Br J Pharmacol
125:
1695-1707,
1998[ISI][Medline].
30.
Weiss, JN.
The Hill equation revisited: uses and misuses.
FASEB J
11:
835-841,
1997[Abstract].
31.
Zhao, W,
Zhang J,
Lu Y,
and
Wang R.
The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener.
EMBO J
20:
6008-6016,
2001[ISI][Medline].
This article has been cited by other articles:
|
|
 |
|
  N. Siebert, D. Cantre, C. Eipel, and B. Vollmar H2S contributes to the hepatic arterial buffer response and mediates vasorelaxation of the hepatic artery via activation of KATP channels Am J Physiol Gastrointest Liver Physiol, December 1, 2008; 295(6): G1266 - G1273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Lim, Y.-H. Liu, E. S. W. Khin, and J.-S. Bian Vasoconstrictive effect of hydrogen sulfide involves downregulation of cAMP in vascular smooth muscle cells Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1261 - C1270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Furne, A. Saeed, and M. D. Levitt Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1479 - R1485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Yang, L. Wu, B. Jiang, W. Yang, J. Qi, K. Cao, Q. Meng, A. K. Mustafa, W. Mu, S. Zhang, et al. H2S as a Physiologic Vasorelaxant: Hypertension in Mice with Deletion of Cystathionine {gamma}-Lyase Science, October 24, 2008; 322(5901): 587 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Geng, Y. Cui, J. Zhao, F. Yu, Y. Zhu, G. Xu, Z. Zhang, C. Tang, and J. Du Hydrogen sulfide downregulates the aortic L-arginine/nitric oxide pathway in rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1608 - R1618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhi, A. D. Ang, H. Zhang, P. K. Moore, and M. Bhatia Hydrogen sulfide induces the synthesis of proinflammatory cytokines in human monocyte cell line U937 via the ERK-NF-{kappa}B pathway J. Leukoc. Biol., May 1, 2007; 81(5): 1322 - 1332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Koenitzer, T. S. Isbell, H. D. Patel, G. A. Benavides, D. A. Dickinson, R. P. Patel, V. M. Darley-Usmar, J. R. Lancaster Jr, J. E. Doeller, and D. W. Kraus Hydrogen sulfide mediates vasoactivity in an O2-dependent manner Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1953 - H1960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bhatia, L. Zhi, H. Zhang, S.-W. Ng, and P. K. Moore Role of substance P in hydrogen sulfide-induced pulmonary inflammation in mice Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L896 - L904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Stipanuk, J. E. Dominy Jr., J.-I. Lee, and R. M. Coloso Mammalian Cysteine Metabolism: New Insights into Regulation of Cysteine Metabolism J. Nutr., June 1, 2006; 136(6): 1652S - 1659S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Leffler, H. Parfenova, J. H. Jaggar, and R. Wang Carbon monoxide and hydrogen sulfide: gaseous messengers in cerebrovascular circulation J Appl Physiol, March 1, 2006; 100(3): 1065 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M R Ebrahimkhani, A R Mani, and K Moore Hydrogen sulphide and the hyperdynamic circulation in cirrhosis: a hypothesis Gut, December 1, 2005; 54(12): 1668 - 1671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Chen, W.-Z. Yao, B. Geng, Y.-L. Ding, M. Lu, M.-W. Zhao, and C.-S. Tang Endogenous Hydrogen Sulfide in Patients With COPD Chest, November 1, 2005; 128(5): 3205 - 3211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Julian, J. Statile, T. A. Roepke, and A. J. Arp Sodium Nitroprusside Potentiates Hydrogen-Sulfide-Induced Contractions in Body Wall Muscle From a Marine Worm Biol. Bull., August 1, 2005; 209(1): 6 - 10. [Full Text] [PDF]
|
|
|
|
|
|
L. F. Gainey Jr. and M. J. Greenberg Hydrogen Sulfide Is Synthesized in the Gills of the Clam Mercenaria mercenaria and Acts Seasonally to Modulate Branchial Muscle Contraction Biol. Bull., August 1, 2005; 209(1): 11 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Dombkowski, M. J. Russell, A. A. Schulman, M. M. Doellman, and K. R. Olson Vertebrate phylogeny of hydrogen sulfide vasoactivity Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R243 - R252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Cheng, J. F. Ndisang, G. Tang, K. Cao, and R. Wang Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2316 - H2323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Dombkowski, M. J. Russell, and K. R. Olson Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2004; 286(4): R678 - R685. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||
